Home LiteratureArticle Details
PMID: 16620112 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter.

Journal of the American Chemical Society ·Vol. 128 ·No. 16 ·2006-04-26 ·Pages 5404-15

Dexheimer TS, Sun D, Hurley LH

Abstract

The human bcl-2 gene contains a GC-rich region upstream of the P1 promoter that has been shown to be critically involved in the regulation of bcl-2 gene expression. We have demonstrated that the guanine-rich strand of the DNA in this region can form any one of three distinct intramolecular G-quadruplex structures. Mutation and deletion analysis permitted isolation and identification of three overlapping DNA sequences within this element that formed the three individual G-quadruplexes. Each of these was characterized using nondenaturing gel analysis, DMS footprinting, and circular dichroism. The central G-quadruplex, which is the most stable, forms a mixed parallel/antiparallel structure consisting of three tetrads connected by loops of one, seven, and three bases. Three different G-quadruplex-interactive agents were found to further stabilize these structures, with individual selectivity toward one or more of these G-quadruplexes. Collectively, these results suggest that the multiple G-quadruplexes identified in the promoter region of the bcl-2 gene are likely to play a similar role to the G-quadruplexes in the c-myc promoter in that their formation could serve to modulate gene transcription. Last, we demonstrate that the complexity of the G-quadruplexes in the bcl-2 promoter extends beyond the ability to form any one of three separate G-quadruplexes to each having the capacity to form either three or six different loop isomers. These results are discussed in relation to the biological significance of this G-quadruplex-forming element in modulation of bcl-2 gene expression and the inherent complexity of the system where different G-quadruplexes and loop isomers are possible.

MeSH Terms
Base Sequence Circular Dichroism DNA/drug effects Genes, bcl-2 Promoter Regions, Genetic
Chemicals
DNA
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dexheimer Thomas S
College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.
Sun Daekyu
Hurley Laurence H
References (71)
71 references, click to expand
  1. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex.
    J Am Chem Soc. 2002 Mar 13;124(10):2098-9 PMID: 11878947
  2. DNA tetraplex formation in the control region of c-myc.
    Nucleic Acids Res. 1998 Mar 1;26(5):1167-72 PMID: 9469822
  3. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure.
    J Am Chem Soc. 2005 Mar 9;127(9):2944-59 PMID: 15740131
  4. Structure and function of telomeres.
    Nature. 1991 Apr 18;350(6319):569-73 PMID: 1708110
  5. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure.
    J Am Chem Soc. 2005 Jul 6;127(26):9439-47 PMID: 15984871
  6. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development.
    Neuron. 1996 Jul;17(1):75-89 PMID: 8755480
  7. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.
    Mol Cell Biol. 1996 Oct;16(10):5546-56 PMID: 8816467
  8. Selective interactions of cationic porphyrins with G-quadruplex structures.
    J Am Chem Soc. 2001 Sep 19;123(37):8902-13 PMID: 11552797
  9. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
    Nature. 2005 Jun 2;435(7042):677-81 PMID: 15902208
  10. The Bcl-2 protein family: arbiters of cell survival.
    Science. 1998 Aug 28;281(5381):1322-6 PMID: 9735050
  11. Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors.
    Development. 1996 Feb;122(2):695-701 PMID: 8625820
  12. Oligonucleotide interactions. 3. Circular dichroism studies of the conformation of deoxyoligonucleotides.
    Biopolymers. 1970;9(9):1059-77 PMID: 5449435
  13. Homodimeric MyoD preferentially binds tetraplex structures of regulatory sequences of muscle-specific genes.
    J Biol Chem. 2005 Jul 22;280(29):26805-12 PMID: 15923190
  14. Highly prevalent putative quadruplex sequence motifs in human DNA.
    Nucleic Acids Res. 2005 May 24;33(9):2901-7 PMID: 15914666
  15. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus.
    J Am Chem Soc. 2001 Feb 14;123(6):1262-3 PMID: 11456694
  16. Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix.
    Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):113-7 PMID: 9465813
  17. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3309-13 PMID: 8159744
  18. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.
    EMBO J. 1988 Jan;7(1):123-31 PMID: 2834197
  19. bcl-2 protein in non-small-cell lung carcinoma.
    N Engl J Med. 1993 Sep 2;329(10):690-4 PMID: 8393963
  20. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death.
    Gene Ther. 2000 Jul;7(14):1244-9 PMID: 10918494
  21. The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4.
    J Am Chem Soc. 2004 Jul 21;126(28):8702-9 PMID: 15250722
  22. Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment.
    Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):193-213 PMID: 12162702
  23. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Oncogene. 2002 May 30;21(24):3898-908 PMID: 12032828
  24. Selective recognition of G-qQuadruplex telomeric DNA by a bis(quinacridine) macrocycle.
    J Am Chem Soc. 2003 Apr 23;125(16):4732-40 PMID: 12696891
  25. The chromosomal basis of human neoplasia.
    Science. 1983 Jul 15;221(4607):227-36 PMID: 6336310
  26. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis.
    Nature. 1988 Jul 28;334(6180):364-6 PMID: 3393228
  27. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
    Cancer Res. 1995 Nov 15;55(22):5386-9 PMID: 7585606
  28. Unusual DNA structure of the diabetes susceptibility locus IDDM2 and its effect on transcription by the insulin promoter factor Pur-1/MAZ.
    Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12508-12 PMID: 11070077
  29. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11593-8 PMID: 12195017
  30. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues.
    Leuk Lymphoma. 1994 Mar;13(1-2):81-7 PMID: 8025526
  31. A DNA polymerase stop assay for G-quadruplex-interactive compounds.
    Nucleic Acids Res. 1999 Jan 15;27(2):537-42 PMID: 9862977
  32. BCL-2 family: regulators of cell death.
    Annu Rev Immunol. 1998;16:395-419 PMID: 9597135
  33. Loop-length-dependent folding of G-quadruplexes.
    J Am Chem Soc. 2004 Dec 22;126(50):16405-15 PMID: 15600342
  34. Stability and structure of telomeric DNA sequences forming quadruplexes containing four G-tetrads with different topological arrangements.
    Biochemistry. 2004 Apr 27;43(16):4877-84 PMID: 15096057
  35. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2.
    Cancer Res. 2001 Sep 15;61(18):6693-7 PMID: 11559537
  36. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade.
    Nucleic Acids Res. 1999 May 15;27(10):2086-90 PMID: 10219080
  37. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Cancer. 1996 Jan 15;77(2):255-64 PMID: 8625232
  38. Template topology and transcription: chromatin templates relaxed by localized linearization are transcriptionally active in yeast.
    Mol Cell Biol. 1997 May;17(5):2825-34 PMID: 9111354
  39. G-quadruplexes as targets for drug design.
    Pharmacol Ther. 2000 Mar;85(3):141-58 PMID: 10739869
  40. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
    J Med Chem. 2001 Dec 6;44(25):4313-24 PMID: 11728179
  41. Anticancer drug resistance and inhibition of apoptosis.
    Anticancer Res. 1994 Nov-Dec;14(6A):2291-4 PMID: 7825961
  42. bcl-2 transgene expression can protect neurons against developmental and induced cell death.
    Proc Natl Acad Sci U S A. 1995 May 9;92(10):4397-401 PMID: 7753817
  43. Porphyrin derivatives for telomere binding and telomerase inhibition.
    Chembiochem. 2005 Jan;6(1):123-32 PMID: 15551357
  44. Solution structure of the Tetrahymena telomeric repeat d(T2G4)4 G-tetraplex.
    Structure. 1994 Dec 15;2(12):1141-56 PMID: 7704525
  45. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.
    Nat Cell Biol. 2001 Feb;3(2):183-91 PMID: 11175751
  46. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas.
    J Biol Chem. 1996 Sep 13;271(37):22687-91 PMID: 8798441
  47. Identification of a p53-dependent negative response element in the bcl-2 gene.
    Cancer Res. 1994 Jun 15;54(12):3131-5 PMID: 8205530
  48. Biophysical and biological properties of quadruplex oligodeoxyribonucleotides.
    Nucleic Acids Res. 2003 Apr 15;31(8):2097-107 PMID: 12682360
  49. Evidence for torsional stress in transcriptionally activated chromatin.
    Mol Cell Biol. 1991 Dec;11(12):6128-38 PMID: 1944280
  50. Formation and properties of hairpin and tetraplex structures of guanine-rich regulatory sequences of muscle-specific genes.
    Nucleic Acids Res. 2005 May 20;33(9):2887-900 PMID: 15908587
  51. The structure of DNA.
    Cold Spring Harb Symp Quant Biol. 1953;18:123-31 PMID: 13168976
  52. Structural transition from antiparallel to parallel G-quadruplex of d(G4T4G4) induced by Ca2+.
    Nucleic Acids Res. 2003 Feb 15;31(4):1156-63 PMID: 12582234
  53. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter.
    J Am Chem Soc. 2004 Jul 21;126(28):8710-6 PMID: 15250723
  54. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
    Cell. 1986 Oct 10;47(1):19-28 PMID: 2875799
  55. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia.
    Stroke. 1995 Sep;26(9):1670-4; discussion 1675 PMID: 7544927
  56. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
    Oncogene. 2003 Sep 11;22(39):7891-9 PMID: 12970736
  57. A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.
    J Biol Chem. 2000 Mar 3;275(9):6499-508 PMID: 10692454
  58. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
    Cancer Res. 1992 Dec 15;52(24):6940-4 PMID: 1458483
  59. The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas.
    J Biol Chem. 1997 Aug 1;272(31):19609-14 PMID: 9235968
  60. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.
    J Med Chem. 2003 Oct 9;46(21):4463-76 PMID: 14521409
  61. A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter.
    Mol Cell Biol. 1993 Jun;13(6):3686-97 PMID: 8388542
  62. Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications.
    Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):25-39 PMID: 15723611
  63. DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibition.
    Mini Rev Med Chem. 2001 May;1(1):31-41 PMID: 12369989
  64. Bcl-2 protein expression and long-term survival in breast cancer.
    Am J Pathol. 1994 Nov;145(5):1191-8 PMID: 7977649
  65. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5214-8 PMID: 3523487
  66. Spectroscopic comparison of different DNA structures formed by oligonucleotides.
    J Biomol Struct Dyn. 1999 Feb;16(4):863-72 PMID: 10217455
  67. The development and use of a DNA polymerase arrest assay for the evaluation of parameters affecting intrastrand tetraplex formation.
    J Biol Chem. 1996 Aug 23;271(34):20958-64 PMID: 8702855
  68. Initiation of transcription by RNA polymerase II is limited by melting of the promoter DNA in the region immediately upstream of the initiation site.
    J Biol Chem. 1994 Dec 2;269(48):30101-4 PMID: 7982911
  69. The human insulin gene linked polymorphic region exhibits an altered DNA structure.
    Nucleic Acids Res. 1992 Jan 25;20(2):231-6 PMID: 1741248
  70. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis.
    Cell. 1993 Apr 23;73(2):295-307 PMID: 8477446
  71. Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines.
    Ann Oncol. 1994;5 Suppl 1:61-5 PMID: 8172820
Article Info
Journal
Journal of the American Chemical Society
Abbr.
J Am Chem Soc
ISSN
0002-7863
Published
2006-04-26
Pages
5404-15
Language
English
Region
United States
NLM ID
7503056
PMCID
PMC2580050
Subset
IM
Grants
NCI NIH HHS · P30 CA023074 · United States
NCI NIH HHS · CA09213 · United States
NCI NIH HHS · CA94166 · United States
NCI NIH HHS · T32 CA009213 · United States
NCI NIH HHS · R01 CA094166 · United States
NCI NIH HHS · T32 CA009213-30 · United States
NCI NIH HHS · R01 CA094166-03 · United States
NCI NIH HHS · R01 CA094166-04 · United States
NCI NIH HHS · R01 CA094166-02 · United States
NCI NIH HHS · R01 CA094166-01 · United States
NCI NIH HHS · R01 CA094166-05 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com